Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:33 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 349 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Long-term outcomes Clear all

Conditions: Kidney Cancer
Interventions: Not listed
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: HIV Infections, HIV Seronegativity
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 24 Hours to 21 Years
Enrollment: 4,150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Ends 2002
U.S. locations: 89
States / cities: Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 52 more

Conditions: Autism Spectrum Disorder
Interventions: Enhanced early detection; Behavioral
Lead sponsor: Drexel University; Other
Eligibility: 16 Months to 58 Months
Enrollment: 2,087 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 3
States / cities: Sacramento, California • Storrs, Connecticut • Philadelphia, Pennsylvania

Conditions: ARDS, Sepsis, Pneumonia
Interventions: Blood collection, Urine Collection, Nasal, oral, and rectal swabs, Stool collection, Heat Moisture Exchange Filter collection, Tracheal Aspirate sample collection, Non-bronchoscopic bronchoalveolar lavage (NBBAL), Surveys, Short physical performance battery, Hand grip strength, CNS Vital Signs, Muscle Ultrasound, Muscle Strength, Spirometry, Lung Diffusion Testing (DLCO), Chest CT Scan; Other · Procedure · Radiation
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 4,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 20
States / cities: Fresno, California • Palo Alto, California • San Francisco, California + 12 more

Conditions: Mild Cognitive Impairment
Interventions: Walking Intervention, Cognitive Training Intervention, Combined Intervention; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 60 Years to 80 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Point Biomedical; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 39
States / cities: Tucson, Arizona • Burlingame, California • Long Beach, California + 32 more

Conditions: Language Development
Interventions: Talk STEM Familia app; Behavioral
Lead sponsor: Oregon Research Behavioral Intervention Strategies, Inc.; Industry
Eligibility: 8 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Telemedicine, Gait, Hemiplegic, Gait Disorders, Neurologic, Stroke, Orthotic Devices, Gait Analysis
Interventions: Delivery of iStride™ device gait treatment using telemedicine; Device
Lead sponsor: Moterum Technologies, Inc.; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Specific Learning Disorder (MeSH Unique ID: D000067559), Dyslexia (MeSH Unique ID: D004410), Conduct Disorder (MeSH Unique ID: D019955)
Interventions: Strategies Enhancing Reading in Older Underperf. Students; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 14 Years to 16 Years · Male only
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Inherited Metabolic Disorders (IMD)
Interventions: Safety and efficacy assessments; Other
Lead sponsor: Magenta Therapeutics, Inc.; Industry
Eligibility: Up to 16 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Brain Tumor, Low Grade Glioma, Astrocytoma, Ependymoma, Ganglioglioma
Interventions: Proton radiotherapy; Radiation
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 1 Year to 25 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Coronary Heart Disease, Stroke, Breast Cancer, Ovarian Cancer, Cancer, Hip Fracture, Death
Interventions: Not listed
Lead sponsor: Parker, William H., M.D.; Other
Eligibility: 30 Years to 55 Years · Female only
Enrollment: 32,175 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1980 – 2004
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Melanoma, Metastatic Melanoma, Advanced Solid Tumor, Hepatocellular Carcinoma
Interventions: Observational study with no interventions; Other
Lead sponsor: Replimune, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2035
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Multiple Sclerosis
Interventions: Not listed
Lead sponsor: Biogen; Industry
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Buffalo, New York • Cleveland, Ohio + 1 more

Conditions: Delirium, Cognitive Decline, Dementia
Interventions: Cognitive Training, Goal Management Training; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 283 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Nashville, Tennessee

Conditions: Early-stage Breast Cancer, Breast Carcinoma in Situ, Breast Neoplasms
Interventions: Intraoperative Radiation Therapy (IORT); Radiation
Lead sponsor: Saint John's Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: COPD
Interventions: Breath Responsive Variable Bolus Oxygen Conserving Device; Device
Lead sponsor: StratiHealth; Industry
Eligibility: 65 Years to 85 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 3
States / cities: Oceanside, California • Vista, California • Westminster, California

Conditions: Cocaine Use Disorder, Contingency Management
Interventions: prize contingency management on a traditional twice weekly schedule for cocaine abstinence, prize contingency management on a variable interval schedule for cocaine abstinence, standard care; Behavioral
Lead sponsor: UConn Health; Other
Eligibility: 18 Years and older
Enrollment: 274 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 4
States / cities: Bridgeport, Connecticut • Hartford, Connecticut • New Britain, Connecticut + 1 more

Conditions: Cholelithiasis
Interventions: Not listed
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Orthopaedic Fractures
Interventions: NSAID, Gabapentinoids, placebo; Drug
Lead sponsor: Major Extremity Trauma Research Consortium; Other
Eligibility: 18 Years to 80 Years
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 17
States / cities: Miami, Florida • West Palm Beach, Florida • Indianappolis, Indiana + 13 more

Conditions: Erdheim-Chester Disease (ECD)
Interventions: Not listed
Lead sponsor: Meyer Children's Hospital IRCCS; Other
Eligibility: 7 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 3
States / cities: Bethesda, Maryland • Rochester, Minnesota • New York, New York

Conditions: Psoriasis
Interventions: Tacrolimus Cream; Drug
Lead sponsor: Astellas Pharma Inc; Industry
Eligibility: 12 Years and older
Enrollment: 658 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 31
States / cities: Birmingham, Alabama • Fresno, California • Santa Monica, California + 26 more

Conditions: Open-angle Glaucoma (OAG)
Interventions: CycloPen Micro-Interventional Cyclodialysis System, CycloPen Micro-Interventional Cyclodialysis System Post Cataract; Procedure
Lead sponsor: Iantrek, Inc.; Industry
Eligibility: Not listed
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 10
States / cities: Newport Beach, California • Cape Coral, Florida • DeLand, Florida + 7 more

Conditions: Hypertension
Interventions: Chart review; Other
Lead sponsor: Louisiana State University Health Sciences Center in New Orleans; Other
Eligibility: 65 Years and older
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New Orleans, Louisiana

Search by objective public record fields.

Participant Reported Outcomes and Treatment Experiences in Kidney Cancer

Long-Term Effects of HIV Exposure and Infection in Children

Promoting Positive Outcomes for Individuals With ASD: Linking Early Detection, Treatment, and Long-term Outcomes

The APS Phenotyping Study

Impact of Combined Behavioral Interventions on Cognitive Outcomes in MCI

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

STEM (Science, Technology, Engineering & Math) Familia Talk

Treatment of Hemiparetic Gait Impairments Using Telehealth With the Moterum iStride Solution™

Reading Remediation and Outcomes in Detention

A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) With MGTA-456

Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation

Examining the Long-Term Risks of Oophorectomy

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Avonex 15 Year Long Term Follow-up Study

Early Cognitive Intervention in Delirium

Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer

A Prospective Observational Study of the Breath Responsive Variable Bolus Oxygen Conserving Device

Extending Long-term Outcomes Through an Adaptive Aftercare Intervention

Cost Effectiveness Analysis of Cholecystectomy, Projected Long Term Outcomes and Complications Evaluation

Improving Pain Management and Long Term Outcomes Following High Energy Orthopedic Trauma (Pain Study)

ECD-Score: a Study on Erdheim-Chester Disease

A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

5-Year Postoperative Outcomes of Patients Who Completed the CREST Study

Hypertension in Long-Term Care Facilities